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Abstract
Background: The apicomplexan parasite Theileria parva causes a livestock disease called East coast fever (ECF), with
millions of animals at risk in sub-Saharan East and Southern Africa, the geographic distribution of T. parva. Over a
million bovines die each year of ECF, with a tremendous economic burden to pastoralists in endemic countries.
Comprehensive, accurate parasite genome annotation can facilitate the discovery of novel chemotherapeutic
targets for disease treatment, as well as elucidate the biology of the parasite. However, genome annotation remains
a significant challenge because of limitations in the quality and quantity of the data being used to inform the
location and function of protein-coding genes and, when RNA data are used, the underlying biological complexity
of the processes involved in gene expression. Here, we apply our recently published RNAseq dataset derived from
the schizont life-cycle stage of T. parva to update structural and functional gene annotations across the entire
nuclear genome.
Results: The re-annotation effort lead to evidence-supported updates in over half of all protein-coding sequence
(CDS) predictions, including exon changes, gene merges and gene splitting, an increase in average CDS length of
approximately 50 base pairs, and the identification of 128 new genes. Among the new genes identified were those
involved in N-glycosylation, a process previously thought not to exist in this organism and a potentially new
chemotherapeutic target pathway for treating ECF. Alternatively-spliced genes were identified, and antisense and
multi-gene family transcription were extensively characterized.
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Conclusions: The process of re-annotation led to novel insights into the organization and expression profiles of
protein-coding sequences in this parasite, and uncovered a minimal N-glycosylation pathway that changes our
current understanding of the evolution of this post-translational modification in apicomplexan parasites.
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Background
East Coast fever (ECF) in eastern, central, and southern Af-
rica causes an estimated loss of over 1 million heads of cat-
tle yearly, with an annual economic loss that surpasses
$300 million USD, impacting mainly smallholder farmers
[1]. Cattle are the most valuable possession of smallholder
farmers in this region, as they are a source of milk, meat
and hides, provide manure and traction in mixed crop-
livestock systems, and revenue derived from livestock pays
for school fees and dowries [2, 3]. ECF is a tick-transmitted
disease caused by the apicomplexan parasite Theileria
parva. Lymphocytes infected with T. parva proliferate in
the regional lymph node draining the tick bite site, and then
metastasize into various lymphoid and non-lymphoid or-
gans, and induce a severe inflammatory reaction that leads
to respiratory failure and death of susceptible cattle, which
typically die within three to four weeks of infection [4–7].
T. parva control is vital to food security in this region of
the world, which is plagued by a range of other infectious
diseases of humans and their livestock.
Efficacious and affordable chemotherapeutics and vac-
cines are essential tools in the effective control of infec-
tious disease agents [8, 9]. A reliable structural annotation
of the genome, consisting at minimum of the correct loca-
tion of all protein-coding sequences (CDSs), enables the
identification, prioritization and experimental screening of
potential vaccine and drug targets [10–12]. The accurate
identification of the complete proteome can greatly en-
hance microbiological studies, and reveals metabolic pro-
cesses unique to pathogens [13]. In turn, a better
understanding of the biology of T. parva transmission,
colonization and pathogenesis may ultimately reveal novel
targets for pathogen control [14]. Currently, much like for
other apicomplexan parasites [15, 16], knowledge on the
functional role of genomic sequences outside of T. parva
CDSs is sparse, and many gene models containing only
CDSs are supported by little or no experimental evidence.
RNAseq data, generated through deep sequencing of
cDNA using next generation sequencing technologies, can
provide an extraordinary level of insight into gene struc-
ture and regulation [12, 17]. Here, we used the first high-
coverage RNAseq data for this species [18] to improve
existing gene models through the identification of start
and stop codons, primary intron splice sites and untrans-
lated regions (UTRs). While RNAseq data exists in pub-
licly available databases for other, closely related
pathogens, such as Theileria annulata and Babesia bovis,
recent systematic re-annotation efforts for these genomes
have yet to be published. This new gene model annotation
brought to light several new insights into gene expression
in this gene-dense eukaryote, and led to the discovery of
several new prospective chemotherapeutic targets for
treating ECF.
Results
The annotation of the Theileria parva genome is
significantly improved, revealing a higher gene density
than previously thought
The nuclear genome of the reference T. parva Muguga iso-
late consists of four linear chromosomes which are cur-
rently assembled into eight contigs (Supplementary Table
S1, Additional File 1): chromosomes 1 and 2 are assembled
into a single contig each, chromosome 3 is in four contigs
and chromosome 4 in two [19]. The new genome annota-
tion was based on this assembly and on extensive RNAseq
data (Supplementary Figure S1, Additional File 1). We per-
formed a comprehensive revision of the entire T. parva
genome annotation, including automated structural anno-
tation and a double-pass manual curation of each locus
(see Methods).
The re-annotation process resulted in the discovery of
128 new genes, 274 adjacent gene models were merged,
157 gene models were split, and 38 genes were replaced
by new genes encoded in the reverse orientation (Fig. 1).
In addition, exon boundaries have been corrected in over
a thousand genes. Overall, 83% of all nuclear genes in the
original annotation were altered in some way, with
changes made on every contig. This resulted in significant
alterations to the predicted proteome, with 53% of the nu-
clear proteins in the original annotation having altered
amino acid sequences in the new annotation, a remarkable
~ 50 bp increase in average CDS length, a reduction of the
average length of intergenic regions by close to 100 bp
and the assignment of an additional 200,000 base pairs (or
2.4% of the genome), previously classified as intergenic or
intronic sequences, to the proteome. This results in a gen-
ome that is denser than previously thought, with an over-
all increase in the coding fraction of the genome from 68
to 71%, more closely resembling T. annulata Ankara,
which has a coding fraction of 72.9% (Supplementary
Table S2, Additional File 1). In fact, T. parva has the dens-
est genome out of the indicated genomes investigated,
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with one protein-coding gene every ~ 2100 bp (Supple-
mentary Table S2, Additional File 1).
Several lines of evidence suggest that this annotation
represents a very significant improvement of the T.
parva proteome relative to the original annotation. First,
there was an increase in the proportion of proteins with
at least one PFAM domain in the new proteome com-
pared to the original proteome, implying that the new
annotation captures functional elements that were previ-
ously missed (Fig. 2a). Given the close evolutionary rela-
tionship and near complete synteny between T. parva
and T. annulata [20], their respective proteomes are ex-
pected to be very similar. Indeed, a comparison of the two
predicted proteomes results in 52 additional reciprocal best
hits and protein length differences between orthologs in T.
parva and T. annulata also decreased significantly (Fig. 2b).
It is likely that some of the most significant differences
between the T. parva and T. annulata proteomes, in par-
ticular the 25% fewer protein-coding genes and much lon-
ger CDSs in the latter, represent annotation errors in the T.
annulata genome that will be corrected upon revision with
more recently accumulated evidence. The total number of
non-canonical splice sites in the genome increased from
0.15 to 0.36% of all introns, but the sequence diversity of
non-canonical splice sites decreased from eight non-
canonical splice donor and acceptor site combinations to
only a single splice site pair – GC/AG donor and acceptor
dinucleotides, recognized by the U2-type spliceosome [21]
(Fig. 2c). The new annotation is also considerably more
consistent with the RNAseq data, with a larger number of
introns, a higher proportion of which is supported by at
least one RNAseq read (Fig. 2d). A total of 118 introns from
the original genome annotation have been removed, due to
contradicting RNAseq evidence.
Fig. 1 Manual gene model curation examples. Several tracks are shown: updated gene model (beige background), original (2005) gene
annotation (grey background), RNAseq data (white background), transcript assembly (dark green, on green background), and EVM predictions
(orange, on green background). a A new gene discovered on the basis of RNAseq data (TpMuguga_03g02005). b A case where two genes in the
2005 annotation merge in the new annotation on the basis of RNAseq read coverage (TpMuguga_04g02435). c A case where a gene in the 2005
annotation has been split into two genes in the new annotation (TpMuguga_04g02190 and TpMuguga_04g02185). d A case where a gene has
been reversed in orientation on the basis of RNAseq data (TpMuguga_02g02095). e A case where overlapping genes led to ambiguity in UTR
coordinates, and so the UTRs were not defined in this intergenic region (TpMuguga_01g00527 and TpMuguga_01g00528). f A case of a single
gene where alternative splicing exists (as seen by significant read coverage in at least one intronic region), but there is one most prevalent
isoform (TpMuguga_03g00622). g A case of two genes that overlap by coding sequences. Coding exons are colored by reading frame
(TpMuguga_05g00017 and TpMuguga_05g00018)
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The tremendous power of RNAseq to inform on gene
and isoform structure in this species revealed a significant
amount of transcriptome diversity and complexity. First,
the proportion of loci (defined here as a continuous gen-
omic region encoding the length of a CDS, intervening in-
trons, and flanking UTRs) that appear to overlap an
adjacent locus increased from 2 to 29% in the new annota-
tion. In many of these instances, read coverage, coding po-
tential, and other evidence support the presence of adjacent
genes with overlapping UTRs (Supplemental Figure S2a).
In 130 cases, the overlap includes not only UTRs but also
CDSs (Supplemental Figure S2b). Secondly, there are many
instances of overlapping loci in which the respective CDSs
are encoded in the same strand; in these cases, no UTRs
were defined in the intervening intergenic region, since
their exact boundaries could not be determined (Add-
itional File 2). Finally, during manual curation, we observed
many instances of potential alternative splicing, the clearest
of which were the cases of well-supported introns where
RNAseq coverage was nevertheless significantly higher than
zero (Supplemental Figure S3; Fig. 1f). In fact, we identified
872 introns, in 490 expressed genes (with average read
coverage > 0), where the read coverage was at least equal to
the mean read coverage for the coding sequences of the re-
spective gene (Supplemental Figure S3b,c; Additional File 3),
instances that are only possible to detect when read cover-
age varies considerably across the gene, which is not un-
common (e.g, Fig. 1c,e). In these cases, only the most
prevalent isoform was annotated (Fig. 1f). Finally, despite its
power, RNAseq evidence is not sufficient to resolve the
Fig. 2 Comparative metrics of original and new T. parva annotations. a The percentage of proteins with at least one PFAM domain found by
Hidden Markov Model searches of the predicted proteomes of the new T. parva Muguga annotation was 2% higher than those in the 2005
annotation, implying that the new annotation captures functional elements that were previously missed. b The new T. parva Muguga annotation
has more reciprocal best-hit orthologs (N) with T. annulata Ankara than the 2005 T. parva Muguga annotation. The variation in protein length
(SD) between T. parva and T. annulata ortholog pairs is greatly reduced in the new relative to the original T. parva annotation. Only nuclear
genes were used for this analysis. The x-axis was limited to the range − 300 to + 300 for easy visual interpretation. c The number of canonical GT/
AG intron splice sites increased and the number of non-canonical intron splice site combinations decreased in the new T. parva Muguga
annotation compared to the 2005 annotation. d The number and proportion of introns validated by at least one RNAseq read increased in the
new T. parva Muguga annotation compared to the 2005 annotation. These lines of evidence suggest that the new annotation is more accurate,
and also considerably more consistent with the RNAseq data, as expected
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structure of all loci; when the evidence did not clearly favor
one gene model over another, the gene model in the ori-
ginal annotation was maintained by default. Interestingly,
the vast majority of the genes appear to have only one or,
sometimes, two most prevalent isoforms, as has been pro-
posed for Plasmodium [22], although this was not defined
quantitatively here. The median length of the annotated
mRNA reported here is ~ 1500 bp, and the maximum
length > 15,000 bp (Supplementary Figure S4, Additional
File 1).
Most genes are transcribed during the schizont stage of
the Theileria parva life-cycle, and antisense transcription
is widespread
We sequenced cDNA generated from polyA-enriched
total RNA collected from a T. parva-infected, schizont-
transformed bovine cell line (see Methods section). A
total of 8.3 × 107 paired-end reads were obtained with an
Illumina HiSeq 2000 platform, 70.04% of which mapped
to the T. parva reference genome (Supplementary Table
S1, Additional File 1). RNAseq provided a complete and
quantitative view of transcription revealing that most of
the genome of this parasite is transcribed during the
schizont stage of its life cycle (Supplementary Figures
S3, S5, Additional File 1). We found that 4011 of all 4054
(98%) predicted protein-coding parasite genes are tran-
scribed at the schizont stage, and 12,172 of all 12,296 in-
trons are supported by RNAseq reads (Fig. 2d). We found
evidence of expression for almost all of the known
humoral and cellular immunity antigens (Supplementary
Table S3, Additional File 1). In fact, Tp9, one of those an-
tigens, is among the 15 most highly expressed genes in
our dataset (Supplementary Table S4, Additional File 1).
Interestingly, its ortholog in T. annulata has been hypoth-
esized to contribute to schizont-induced host cell trans-
formation [23].
As has recently been suggested from in silico analyses
[18], transcription in T. parva occurs from diverse kinds
of promoters, with many instances of adjacent loci over-
lapping on the same or opposite strands. In fact, of the
4085 predicted protein-coding nuclear genes, only 74
had an estimated reads per kilobase of transcript per
million reads (RPKM) of zero and an additional 154 had
RPKM< 1. Interestingly, of the 74 genes with an RPKM
of zero, most are hypothetical, with no predicted func-
tional annotation, and without any high-confidence
orthologs (Supplementary Table S5, Additional File 1).
Since tRNAs are not polyadenylated, they were not
found in our RNAseq dataset (Materials and Methods).
Annotated protein-coding genes lacking RNAseq evidence
are mostly orthologs of Plasmodium falciparum apicoplast
proteins with mid-blood stage expression [24, 25], T. parva
repeat (Tpr) family proteins, or DUF529 domain-containing
proteins (Supplementary Table S5, Additional File 1). These
data are consistent with a study published in 2005, which
used MPSS to estimate expression levels of T. parva genes
in the schizont stage of the parasite [26], as well as a more
recent study comparing gene expression between the schiz-
ont and the sporozoite/sporoblast stages [27]. The expression
levels in the sense strand for each gene, as quantified by
RPKM, when log-transformed, followed a unimodal distribu-
tion similar to a normal distribution (Fig. 3a).
T. parva multi-gene families show variable expression
levels
Large gene families are known to play a role in the patho-
genesis of protozoan infections, perhaps the most well-
known being the var gene family in P. falciparum. These
genes encode proteins that are essential for the sequestra-
tion of infected red blood cells, a critical biological feature
determining severe malaria pathology of P. falciparum
[28]. Using the OrthoMCL algorithm as described previ-
ously [19], we clustered paralogs in this genome, identify-
ing changes in the size of several of the largest T. parva
gene families (Supplementary Table S6, Additional File 1),
and finding variable patterns in their levels of expression
(Supplementary Figure. S6, Additional File 1). The roles of
most of these gene families are not known. For example,
the Tpr (T. parva repeat) gene family has been suggested
to be rapidly evolving and expressed as protein in the
piroplasm stages [19]. This is consistent with our findings,
which show Tpr genes not to be highly expressed in the
schizont (Supplementary Figure S6, Additional File 1) or
the sporoblast (Supplementary Figure S7, Additional File
1) stages [27, 29]. Interestingly, in that same dataset, we
find a significant up-regulation of subtelomeric variable
secreted protein gene (SVSP) family genes in the sporozo-
ite stages relative to both the sporoblast and schizont
stages, suggesting that they may be important for invasion
or the establishment of infection in the vertebrate host
(Supplementary Figure S7, Additional File 1) [30].
This new T. parva genome annotation not only improved
our resolution of the gene models of multi-gene family
members and other transformation factors (Supplementary
Figure S8, Additional File 1) [31], but also uncovered 128
genes that were not present in the original annotation.
A mechanism of core N-glycosylation is now predicted in
T. parva
Among the 128 newly identified genes, one was anno-
tated as a potential Alg14 ortholog, an important part of
a glycosyltransferase complex in many organisms that
add a N-acetylglucosamine (GlcNAc) to the N-glycan
precursor. N-glycosylation is an important type of pro-
tein post-translation modification, during which a sugar
is linked to the nitrogen of specific amino acid residues,
a process that occurs in the membrane of the endoplas-
mic reticulum and is critical for both the structure and
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function of many eukaryotic proteins. N-glycosylation is
a ubiquitous protein modification process, but the gly-
cans being transferred differ among the domains of life
[32]. However, in apicomplexan parasites that infect red
blood cells, there appears to be a selection against long
N-glycan chains [33]. Theileria parasites were previously
believed to not add N-acetylglucosamine to their glycan
precursors, since sequence similarity searches did not
identify the necessary enzymes. While the study by Sam-
uelson and Robbins [33] did not discover any Alg en-
zymes, we find that T. parva has Alg7 (TpAlg7;
TpMuguga_01g00118), Alg13 (TpAlg13; TpMuguga_
02g00515), and Alg14 (TpAlg14; TpMuguga_01g02045)
homologs, which show differential mRNA-level expres-
sion between the sporozoite and schizont life cycle
stages (Supplementary Figure S9, Additional File 1). In
fact, the structure of each of these Theileria proteins can
be predicted ab initio with high confidence (Supplemen-
tary Table S7, Additional File 1) and have predicted sec-
ondary structural characteristics very similar to their
homologs in Saccharomyces cerevisiae (Fig. 4a). How-
ever, the structure of the TpAlg7-encoding locus was al-
tered as a result of the re-annotation effort and TpAlg14
is the product of a newly identified gene, which might
have prevented the original identification of the pathway.
Therefore, Theileria parasites likely have a minimal N-
glycosylation system. Interestingly, we can find Alg14
orthologs by blastp search in T. orientalis (TOT_
010000184), T. equi (BEWA_032670), but not in T.
annulata. Using the adjacent gene, EngB, as a marker, a
look at the T. annulata genomic region that is syntenic
to TpAlg14 revealed that T. annulata has a hypothetical
gene annotated on the opposite strand (Fig. 4b), which
could be an incorrect annotation. A tblastn search of the
T. annulata genome using TpAlg14 led to the discovery
of a nucleotide sequence which translated results in an
alignment with E-value of 7 × 10− 15 and 70% identity
over the length of the protein, suggesting the existence
of an T. annulata Alg14 ortholog (TaAlg14). In fact, the
gene model that was at the TpAlg14 locus in the original
annotation, TP01_0196, was likely a result of an incor-
rect annotation transfer from T. annulata (or vice-
versa), since TP01_0196 shared 52% identity with the
gene annotated on the opposite strand at the putative
TaAlg14 locus (E-value 4 × 10− 131). Since previous stud-
ies have used T. annulata as a model Theileria parasite,
this could be the reason that N-glycosylation was not
discovered in this parasite genus.
While the presence of N-glycans in Plasmodium para-
site proteins was initially controversial [37], more recent
work provided evidence of short N-glycans on the exter-
ior of P. falciparum schizonts and trophozoites [38]. As
a key difference, Plasmodium parasites have a clear
ortholog of the oligosaccharyl transferase STT3 (EC
2.4.99.18, PF3D7_1116600 in P. falciparum 3D7), which
catalyzes the transfer of GlcNAc and GlcNAc2 to aspara-
gine residues in nascent proteins, and recent work has
identified several other proteins in this protein complex
in Plasmodium genomes [37]. No such ortholog was
found in T. parva Muguga or T. annulata Ankara by
Fig. 3 Distribution of RNAseq RPKM values for T. parva Muguga genes (a) A histogram of sense RPKM values after logarithmic transformation of
the data. Frequencies on the y-axis correspond to probability density. The blue line shows a normal distribution around the same median, while
the red line shows a more reliable fixed-width, Gaussian, kernel-smoothed estimate of the probability density. b The sense (green) and antisense
(red) reads per kilobase transcript per million reads (RPKM) after fourth-root transformation of the data. Genes are sorted by position on the
chromosome for all four nuclear chromosomes of T. parva Muguga
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blastp or tblastn searches with the Plasmodium protein.
Since there are STT3 orthologs in T. equi and T. haneyi
(Fig. 4c), as well as Cytauxoon felis, it appears that the
absence of STT3 in T. parva and T. annulata represents
evolutionary loss of STT3 orthologs in this lineage. This
means that while lipid precursor N-glycosylation does
likely occur at the ER in these two species, the canonical
mechanism of N-glycan precursor transfer to proteins is
apparently absent.
Discussion
The re-annotation of the T. parva genome has resulted
in significant improvement to the accuracy of gene
models, showing that this genome is even more gene-
dense than previously thought, with the addition of 2.4%
of the genome to CDSs as well as the discovery of add-
itional overlapping genes. This re-annotation has im-
proved our understanding of the biology of the parasite,
from contributions of both single copy genes [39] and
multi-gene families. Multi-gene families appear to have
played a prominent role in the evolution of the lineage
leading to T. parva and T. annulata [40], implying a role
for these genes in host-pathogen interactions. These
genes have diversified and/or expanded in copy number,
possibly as an adaptation to a particular niche, since the
high density of the genome is strongly suggestive of selec-
tion against non-functional DNA. We now have a clearer
picture of the structure, copy number, and relative expres-
sion level of these genes. In addition, a recently generated
sporozoite and sporoblast datasets opens up new oppor-
tunities to study differential gene expression throughout
other stages of the parasite life cycle [27].
The model of transcription that emerges from these
recent studies is one of ubiquitous transcription of most
genes in the schizont stage, but with a wide range of ex-
pression levels [18, 26, 27], suggesting that there are
likely important cis regulatory motifs that control the
level of expression or mRNA stability [18, 41]. Tran-
scription can also arise from potential bidirectional and
cryptic promoters with highly prevalent antisense tran-
scription. It remains to be determined if sense and anti-
sense transcripts are generated in the same or different
cells in culture, an issue that may be addressed with
single-cell RNAseq. Due to the short-read nature of our
sequencing platform, we were only able to accurately an-
notate the most prevalent isoform of each gene. The se-
quencing of full-length transcripts, for example with
Pacific Biosciences sequencing technology, would
Fig. 4 The uncovered Theileria parva Alg14 shows a similar predicted structure to the empirically determined Saccharomyces cerevisiae Alg14
protein structure, and is syntenic in multiple piroplasms. a A Phyre2 prediction of T. parva Alg14 (TpAlg14; green; TpMuguga_01g02045) and the
Protein Database (http://www.rcsb.org/) [34] nuclear magnetic resonance structure of Saccharomyces cerevisiae Alg14 (ScAlg14; teal; PDB 2JZC)
were aligned in MacPyMol (https://pymol.org/2/) [35]. b Shown are the syntenic regions around Alg14 orthologs (synteny in grey), using the
adjacent gene EngB as an anchor (synteny in red) in the Sybil software package [36]. c Shown are the syntenic regions around STT3 orthologs
(synteny in grey), using a B. bovis STT3-adjacent gene (BBOV_II000210) as an anchor (synteny in red) in the Sybil software package
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provide a more comprehensive description of the T.
parva transcriptome, including alternatively spliced vari-
ants and the boundaries of overlapping transcripts.
In yeast and humans, antisense transcription, defined by
the existence of non-coding RNA encoded on the DNA
strand opposite to, and overlapping with, that encoding
the mRNA, is rare compared to sense transcription [42].
In T. parva, however, antisense transcription is highly
prevalent throughout the genome (Fig. 3b), as has been
found in P. falciparum, where antisense transcription is
synthesized largely by RNA polymerase II [43, 44] and can
alter the expression of multigene family members by regu-
lating the packaging of these loci into chromatin [45].
Most of the antisense transcripts seem to completely over-
lap with their sense counterparts, although the functional
relevance of this observation has yet to be determined.
The discovery of evidence that N-glycosylation may
occur in Theileria parasites could open up novel treat-
ment options against Theileria infections. N-glycosylation
is thought to be important for Toxoplasma gondii inva-
sion, growth, and motility [46–48]. While the results are
somewhat confounded by a lack of inhibitor specificity,
treatment with the N-glycosylation inhibitor tunicamycin
results in parasites with abnormal endoplasmic reticulum,
malformed nuclei, and impaired secretory organelles [49].
While once controversial due to differences in analytical
methods, parasite life-cycle stages, and host contamin-
ation, P. falciparum is now thought to have N-
glycosylated proteins, although this is not as frequent a
mechanism of protein modification as glycosylphosphati-
dylinositol [50] . This work has been supported by bio-
informatic analyses, finding that P. falciparum contains
glycosyltransferases (albeit few) [51]. Early work using N-
glycosylation inhibitors has shown strong in vitro growth
inhibition of Plasmodium asexual blood stages [52–56],
but the function of N-glycosylation of apicomplexan para-
site proteins is a topic that requires further study. Import-
antly, the lack of an STT3 ortholog in T. parva, if true,
would suggest that protein-targeted N-glycosylation does
not occur in this parasite (as does in Plasmodium), and
may only occur on the ER and potentially the surface of the
parasite. Even though cytoplasmic N-glycosyltransferases
have been found in bacteria, they have not been found in
eukaryotes, and their presence in T. parva seems unlikely.
The absence of a N-glycan protein transfer system is largely
supported by genome-wide searches for the enrichment of
N-glycan acceptor sites in T. annulata [57]. While N-
glycosylation is often touted as an ‘essential’ protein modifi-
cation in eukaryotes [58], the absence of an STT3 ortholog
in some Theileria species suggests that this process may be
critical as a lipid, rather than protein, modification. This
does not diminish the potential relevance of N-
glycosylation in these parasites. Regardless of whether these
short N-glycans provoke host immune responses or play a
homeostatic role in parasite protein folding, they could be
important therapeutic targets. Finally, given the possibility
that glycans encode immunological ‘self’, ‘non-self’ or ‘dam-
age’ identities [59], it is tempting to speculate that the ab-
sence of proteinaceous N-glycans in Theileria species could
represent an evolutionary adaptation to immune evasion in
a parasite lineage that resides free in the host cytoplasmic
environment.
Conclusions
This study emphasizes the critical interplay between gen-
ome annotations and our knowledge of pathogen biology.
The significant improvement of the T. parva Muguga refer-
ence genome gene annotation will facilitate numerous stud-
ies of this parasite, and has already given better resolution
to genome-wide patterns of gene transcription, including
antisense transcription and transcription of multi-gene fam-
ilies. The better the resolution at which we understand gene
structure and expression, the more accurately we can
characterize and study gene function, novel druggable path-
ways suitable for interventions and, ultimately, the biology
of the pathogen in its different host organisms. For ex-
ample, the discovery of N-glycosylation precursors in some
Theileria parasites in the absence of a protein transfer sys-
tem opens up new questions about the role of lipid N-
glycosylation precursors in eukaryote biology as well as the
potential evolutionary reasons why protein N-glycosylation
would be lost in this apicomplexan lineage.
Methods
RNA sample generation and sequencing
An RNA sample was obtained from a culture of the refer-
ence T. parva isolate (Muguga), from the haploid schizont
stage of the parasite life cycle, which proliferates in host
lymphocytes. The extraction method included comple-
ment lysis of schizont-infected host lymphocytes, DNase
digestion of contaminating host DNA and differential cen-
trifugation to enrich for schizonts [26, 60]. PolyA-
enriched RNA was sequenced using Illumina sequencing
technology, to produce strand-specific RNAseq data.
RNAseq reads were aligned with TopHat and RPKM
values calculated using HTseq [61].
Genome re-annotation
For the re-annotation of the Theileria parva genome, a
number of evidence tracks were generated and loaded into
the genome browser JBrowse [62] for manual curation
using the WebApollo plugin [63]. RNAseq reads were
aligned to the genome with TopHat [64], a splice-aware
alignment tool (Supplementary Table S1, Additional File 1).
These alignments were used to generate strand-specific
read alignment coverage glyphs and XY plots for
visualization in WebApollo. TopHat alignment also yields a
file of all reported splice junctions using segmented
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mapping and coverage information, which is useful for cur-
ating intron splice sites. RNAseq reads were also assembled
into transcripts using CuffLinks [65] and mapped to the
genome with TopHat. We also generated two genome-
dependent Trinity/PASA [66] transcriptome assemblies
(one reference annotation-dependent and one independent
of the reference annotation), as well as one completely de
novo Trinity transcriptome assembly. A variety of other
proteome data were aligned to the genome with AAT [67]
and used as evidence tracks, including previously generated
Theileria annulata mass spectrometry data [68], and all
non-Theileria apicomplexan proteins from NCBI’s RefSeq.
In order to assess gene prediction accuracy before the
manual curation phase, a set of 342 high-confidence T.
parva gene models were selected from the current refer-
ence annotation on the basis of two criteria: (1) RNAseq
reads must cover each exon in the gene, (2) Trinity de
novo assembled transcripts and read coverage must be
concordant with the presence or absence of any introns
in the gene model. Out of these 342 genes, 50 were ran-
domly selected as a validation set and the remaining 292
were used as a training gene set for gene prediction soft-
ware. The exon distribution of the validation set closely
resembles that of the training set (Supplementary Table
S8, Additional File 1).
Multiple gene prediction software tools were used and
then assessed by the accuracy with which they predict
the validation set using an in-house script. These in-
cluded: i) Augustus [69], using RNAseq reads, the T.
parva training gene set, or no evidence; ii) Semi-HMM-
based Nucleic Acid Parser (SNAP) [70] and Glimmer
[71] were trained with the T. parva training set; iii) Fge-
nesh [72] used a pre-existing training set of Plasmodium
genes from its website; iv) the ab initio predictor
GeneMark-ES [73]. Finally, gene models were selected
with the consensus predictor Evidence Modeler (EVM)
[74], using 57, differently-weighted combinations of the
other evidence, while maximizing prediction accuracy
(Supplementary Figure S8, Additional File 1). Based on
their performance in comparison with the validation set,
only the top four EVM predictions were loaded as evi-
dence tracks for use in manual curation (Supplementary
Figure S10, Additional File 1). tRNA and rRNA predic-
tions were generated using tRNAscan-SE [75] and
RNAmmer [76] and loaded as evidence tracks, along
with the original T. parva Muguga annotation (Sup-
plementary Figures S11, S12, Additional File 1). A
genome-wide, double-pass, manual curation of all
gene models was completed, weighing the RNAseq
evidence over the evidence from alignments with ho-
mologs from other species and the gene prediction
programs. The annotation assignments were allocated
in 50 kb segments, with different annotators doing ad-
jacent segments, as well as altering the annotator for
the first and second pass in order to reduce annotator
bias.
Functional annotation of the T. parva proteome con-
sisted of HMM3 searches of the complete proteome
against our custom HMM collection that includes TIGR-
Fams [77], Pfams [78], as well as custom-built HMMs [79]
and RAPSearch2 searches against UniRef100 (with a cut-
off of 1 × 10− 10). In addition, a TMHMM search which
was used to assign “putative integral membrane protein”
to proteins with 3 of more helical spans (assuming there
were no other hits to the previous searches). These
searches were synthesized using Attributor (https://github.
com/jorvis/Attributor) to generate the final annotation
based on the different evidence sources to assign gene
product names, EC numbers, GO terms and gene symbols
to genes, conservatively where possible.
Multi-gene family clustering
Genes were clustered with OrthoMCL, using an inflation
value of 4 and a BLAST p-value cutoff of 10− 5, as previ-
ously done [19]. All individual conserved domain
searches were done using NCBI’s Conserved Domain
Database version 3.11 [80] with 45,746 PSSMs, with an
E-value threshold of 0.01 and a composition based statis-
tics adjustment. HMM searches of the entire PFAM
database were done using default settings.
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